---
title: "AXL"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene AXL"
tags: ['GeneAXL', 'ReceptorTyrosineKinase', 'Cancer', 'DrugTarget', 'Bemcentinib', 'Cabozantinib', 'TP0903', 'DrugResistance']
---

## Gene AXL

**Function:** The gene AXL encodes for a receptor tyrosine kinase that plays a role in various cellular processes such as cell survival, proliferation, adhesion, and migration. It is implicated in the regulation of immune response, cancer, and viral infections.

**External IDs:**
- HGNC: 891
- NCBI Entrez: 558
- Ensembl: ENSG00000147133
- OMIM: 600768
- UniProtKB/Swiss-Prot: P30530

**Aliases:** UFO, JTK11

**AA mutation list:**
- p.Asp128Asn (rs139840125)
- p.Val149Met (rs148919931)
- p.Gly170Cys (rs758697289)

**Mutation type:** Missense

**Somatic SNVs/InDels with dbSNP ID:**
- c.1933A>G (rs267606871)

**Related disease:** The overexpression of AXL has been implicated in various types of cancer such as lung, breast, ovarian, pancreatic, and gastric cancer.

**Treatment and prognosis:** Inhibitors of AXL are being developed and tested as potential anti-tumor agents.

**Drug response:** Several drugs targeting AXL are in pre-clinical and clinical trials such as bemcentinib, cabozantinib, and TP-0903.

**Related papers:**
- Subject: AXL as a therapeutic target in cancer
- Author: Hafizi, S.
- DOI: 10.1016/j.biochi.2016.12.023

- Subject: The role of AXL in drug resistance and epithelial-to-mesenchymal transition of cancer cells
- Author: Zhang, Z. et al.
- DOI: 10.3390/ijms18020340

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**